The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Tuberculosis Testing-Global Market Insights and Sales Trends 2024

Tuberculosis Testing-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1823097

No of Pages : 102

Synopsis
Tuberculosis is a highly infectious bacterial infection, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. Tuberculosis (TB) can be caught by breathing in air that an infected person has contaminated through: Breathing, coughing. Furthermore, the disease is ranked second leading cause of death, after human immunodeficiency virus (HIV). Individual majorly suffer from two predominant forms of TB: Active tuberculosis and Latent tuberculosis. The global tuberculosis testing market comprises diagnostic tests, equipment’s and testing procedures that contribute assistance in diagnostic of tuberculosis infection.
The global Tuberculosis Testing market size is expected to reach US$ 2878.6 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis Testing in various end use industries. The expanding demands from the Hospitals, Laboratories and Others,, are propelling Tuberculosis Testing market. Smear Microscopy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nucleic Acid Testing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Tuberculosis Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Tuberculosis Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis Testing covered in this report include Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific and bioMérieux SA, etc.
The global Tuberculosis Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Akonni Biosystems
Abbott
Becton, Dickinson and Company
Cepheid
Epistem Holdings Plc
F. Hoffmann-La Roche AG
Thermo Fischer Scientific
bioMérieux SA
Siemens Healthineer
Global Tuberculosis Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis Testing market, Segment by Type:
Smear Microscopy
Nucleic Acid Testing
Radiography
Culture Based Tests
Drug Susceptibility Testing
Others
Global Tuberculosis Testing market, by Application
Hospitals
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tuberculosis Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Tuberculosis Testing
1.1 Tuberculosis Testing Market Overview
1.1.1 Tuberculosis Testing Product Scope
1.1.2 Tuberculosis Testing Market Status and Outlook
1.2 Global Tuberculosis Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Tuberculosis Testing Market Size by Region (2018-2029)
1.4 Global Tuberculosis Testing Historic Market Size by Region (2018-2023)
1.5 Global Tuberculosis Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Tuberculosis Testing Market Size (2018-2029)
1.6.1 North America Tuberculosis Testing Market Size (2018-2029)
1.6.2 Europe Tuberculosis Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Tuberculosis Testing Market Size (2018-2029)
1.6.4 Latin America Tuberculosis Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Tuberculosis Testing Market Size (2018-2029)
2 Tuberculosis Testing Market by Type
2.1 Introduction
2.1.1 Smear Microscopy
2.1.2 Nucleic Acid Testing
2.1.3 Radiography
2.1.4 Culture Based Tests
2.1.5 Drug Susceptibility Testing
2.1.6 Others
2.2 Global Tuberculosis Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Tuberculosis Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Tuberculosis Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Tuberculosis Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Tuberculosis Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Tuberculosis Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Tuberculosis Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Tuberculosis Testing Revenue Breakdown by Type (2018-2029)
3 Tuberculosis Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Laboratories
3.1.3 Others
3.2 Global Tuberculosis Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Tuberculosis Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Tuberculosis Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Tuberculosis Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Tuberculosis Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Tuberculosis Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Tuberculosis Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Tuberculosis Testing Revenue Breakdown by Application (2018-2029)
4 Tuberculosis Testing Competition Analysis by Players
4.1 Global Tuberculosis Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Testing as of 2022)
4.3 Date of Key Players Enter into Tuberculosis Testing Market
4.4 Global Top Players Tuberculosis Testing Headquarters and Area Served
4.5 Key Players Tuberculosis Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Tuberculosis Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Tuberculosis Testing Products, Services and Solutions
5.1.4 Abbott Laboratories Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Akonni Biosystems
5.2.1 Akonni Biosystems Profile
5.2.2 Akonni Biosystems Main Business
5.2.3 Akonni Biosystems Tuberculosis Testing Products, Services and Solutions
5.2.4 Akonni Biosystems Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Akonni Biosystems Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Tuberculosis Testing Products, Services and Solutions
5.3.4 Abbott Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Becton, Dickinson and Company Recent Developments
5.4 Becton, Dickinson and Company
5.4.1 Becton, Dickinson and Company Profile
5.4.2 Becton, Dickinson and Company Main Business
5.4.3 Becton, Dickinson and Company Tuberculosis Testing Products, Services and Solutions
5.4.4 Becton, Dickinson and Company Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Becton, Dickinson and Company Recent Developments
5.5 Cepheid
5.5.1 Cepheid Profile
5.5.2 Cepheid Main Business
5.5.3 Cepheid Tuberculosis Testing Products, Services and Solutions
5.5.4 Cepheid Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Cepheid Recent Developments
5.6 Epistem Holdings Plc
5.6.1 Epistem Holdings Plc Profile
5.6.2 Epistem Holdings Plc Main Business
5.6.3 Epistem Holdings Plc Tuberculosis Testing Products, Services and Solutions
5.6.4 Epistem Holdings Plc Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Epistem Holdings Plc Recent Developments
5.7 F. Hoffmann-La Roche AG
5.7.1 F. Hoffmann-La Roche AG Profile
5.7.2 F. Hoffmann-La Roche AG Main Business
5.7.3 F. Hoffmann-La Roche AG Tuberculosis Testing Products, Services and Solutions
5.7.4 F. Hoffmann-La Roche AG Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.7.5 F. Hoffmann-La Roche AG Recent Developments
5.8 Thermo Fischer Scientific
5.8.1 Thermo Fischer Scientific Profile
5.8.2 Thermo Fischer Scientific Main Business
5.8.3 Thermo Fischer Scientific Tuberculosis Testing Products, Services and Solutions
5.8.4 Thermo Fischer Scientific Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Fischer Scientific Recent Developments
5.9 bioMérieux SA
5.9.1 bioMérieux SA Profile
5.9.2 bioMérieux SA Main Business
5.9.3 bioMérieux SA Tuberculosis Testing Products, Services and Solutions
5.9.4 bioMérieux SA Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.9.5 bioMérieux SA Recent Developments
5.10 Siemens Healthineer
5.10.1 Siemens Healthineer Profile
5.10.2 Siemens Healthineer Main Business
5.10.3 Siemens Healthineer Tuberculosis Testing Products, Services and Solutions
5.10.4 Siemens Healthineer Tuberculosis Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Siemens Healthineer Recent Developments
6 North America
6.1 North America Tuberculosis Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Tuberculosis Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Tuberculosis Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Tuberculosis Testing Market Dynamics
11.1 Tuberculosis Testing Industry Trends
11.2 Tuberculosis Testing Market Drivers
11.3 Tuberculosis Testing Market Challenges
11.4 Tuberculosis Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’